These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 563932)

  • 1. Clindamycin in infective endocarditis.
    Cherubin CE; Nair SR
    JAMA; 1978 Feb; 239(7):626-7. PubMed ID: 563932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular clindamycin for therapy of infective endocarditis. Report of 23 cases and review of the literature.
    Burch KH; Quinn EL; Cox F; Madhavan T; Fisher E; Romig D
    Am J Cardiol; 1976 Dec; 38(7):929-33. PubMed ID: 998528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse of staphylococcal endocarditis after clindamycin therapy.
    Tuazon CU; Sheagren JN
    Am J Med Sci; 1975; 269(1):145-8. PubMed ID: 1130433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin therapy of experimental Staphylococcus aureus endocarditis.
    Scheld WM; Johnson ML; Gerhardt EB; Sande MA
    Antimicrob Agents Chemother; 1982 Apr; 21(4):646-9. PubMed ID: 7081981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary report.
    Casalta JP; Zaratzian C; Hubert S; Thuny F; Gouriet F; Habib G; Grisoli D; Deharo JC; Raoult D
    Int J Antimicrob Agents; 2013 Aug; 42(2):190-1. PubMed ID: 23796892
    [No Abstract]   [Full Text] [Related]  

  • 7. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin.
    Watanakunakorn C
    Am J Med; 1976 Mar; 60(3):419-25. PubMed ID: 1045861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin, endocarditis, hepatotoxicity.
    Elmore MF; Rink LD; Rissing JP
    Ann Intern Med; 1973 May; 78(5):779-80. PubMed ID: 4711784
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic treatment of staphylococcal septicaemia and endocarditis in a Swedish hospital.
    Svanbom M
    Scand J Infect Dis Suppl; 1983; 41():161-72. PubMed ID: 6589754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
    Levin TP; Suh B; Axelrod P; Truant AL; Fekete T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1222-4. PubMed ID: 15728934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of subacute bacterial endocarditis treated with parentaral clindamycin (clindamycin 2-phosphate).
    Freeman R; Roberts DW
    Postgrad Med J; 1976 Sep; 52(611):595-7. PubMed ID: 790353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of bacterial endocarditis].
    Halawa B
    Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial endocarditis treated with intramuscular teicoplanin.
    Chauhan S; D'Cruz S; Sachdev A; Singh R
    Singapore Med J; 2007 Sep; 48(9):e248-9. PubMed ID: 17728952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephapirin therapy in infective endocarditis.
    Burch KH; Quinn EL; Saravolatz LD; Madhavan T; Jovanovich JF; Pohlod D
    South Med J; 1983 Apr; 76(4):448-52. PubMed ID: 6836358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus bovis endocarditis.
    Haldane EV; Haldane JH; Digout G; West A; van Rooyen CE
    Can Med Assoc J; 1974 Oct; 111(7):678-9, 82. PubMed ID: 4415908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Bacteroides endocarditis with carbenicillin.
    Al-Ibrahim MS; Holzman RS
    Am J Med Sci; 1977; 273(1):105-7. PubMed ID: 15455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo development of resistance to clindamycin by Staphylococcus aureus.
    Borges JS; Schleider M; Roberts RB
    Postgrad Med; 1975 Jul; 58(1):153-4. PubMed ID: 1041393
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Lodise TP; McKinnon PS; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent bacteremia in staphylococcal endocarditis.
    Reymann MT; Holley HP; Cobbs CG
    Am J Med; 1978 Nov; 65(5):729-37. PubMed ID: 707532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.